Paul Windt is an accomplished leader in clinical operations with over three decades of experience in the pharmaceutical and biotech industries. Currently serving as Vice President of Clinical Operations at Pathos since August 2025, Windt has previously held prominent roles including VP of Clinical Development Operations at Werewolf Therapeutics, Global Head of Clinical Operations in Translational Clinical Oncology at Novartis Institutes for BioMedical Research, and Head of Clinical Operations at Cara Therapeutics. Windt's career also includes senior positions at Regeneron Pharmaceuticals, ImClone, Hoffmann-La Roche, and experience in clinical and pharmacy settings at Thomas Jefferson University Hospital and Underwood Memorial Hospital. Educational credentials include a Bachelor of Science in Pharmacy from Rutgers University, an MBA in Health Administration from Widener University, and a Doctor of Pharmacy from Midwestern University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices